ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase

Size: px
Start display at page:

Download "ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase"

Transcription

1 Journal of Antimicrobial Chemotherapy (1996) 37, ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase E. Culebras**, J. L. Martinez**, F. Baquero* and J. C. P6rez-Diaz* "Centro Nactonal de Biotecnologia (CSIC), Campus (JAM, Cantoblanco, Madrid; h Servicio de Microbiologia, Hospital Ramon y Cajal, Carretera de Colmenar Km 9,100, Madrid, Spain The kinetic constants of the aminoglycoside-modifying enzyme 6'-/V-aminoglycoside acetyltransferase (AAC(6')IV) from the clinical strain Staphylococcus epidermidis RYC differed depending on whether tobramycin and amikacin (glucosamine group) or gentamicin and netilmicin (garosamine group) were used as substrates. Acetylation of the glucosamine antibiotics was highly susceptible to substrate inhibition which increased with ph whereas the garosamine group compounds showed limited substrate inhibition over a wide ph range. These differences in activity correlated with MIC values of S. epidermidis RYC for different aminoglycosides. Aminosugars moiety and ph markedly influenced the AAC(6')FVaminoglycoside interactions. Introduction Resistance to gentamicin and the related aminoglycosides, tobramycin and kanamycin, which is primarily due to the production of antibiotic-inactivating enzymes, is common in nosocomial strains of staphylococci isolated in hospitals around the world (Graham, 1981; Wiedemann & Kresken, 1984; Guimaraes, Sage & Noone, 1985; Davies, 1994). The recent spread of multiresistant methicillin-resistant staphylococcus (Mulligan &, 1993; Lencastre et al., 1994; Swartz, 1994) may increase this antibiotic resistance problem. In the case of antibiotic-inactivating enzymes, enzymatic modification of an aminoglycoside does not necessarily imply a clinical resistance to this drug. Resistance to an aminoglycoside appears to be a function of the ratio between accumulation and modification velocities of the drug. This ratio is determined by the amount of antibiotic at the site of infection, the permeability characteristics of bacteria, and the activity of the antibiotic-inactivating enzyme. Hence the knowledge of kinetic constant values is essential for the understanding of this process. Several studies with the enzymes aminoglycoside nucleotidyl transferase (2") (Bongaerts & Molendijik, 1984), gentamicin acetyltransferase I (Williams & Northrop, 1978) and kanamycin acetyltransferase (Radika & Northrop, 1984), have shown that aminoglycoside resistance mediated by inactivating enzymes is a function of the hydrolytic constant V^K^. 'Corresponding author /96/ $12.00/ The British Society for Antimicrobial Chemotherapy

2 882 E. Culebras et at. Although environmental ph is known to affect the activities of many antibiotics, including aminoglycosides (Bryan, 1984; Thrupp, 1980), little is known about the effect of this factor on the kinetic constants of antibiotic-inactivating enzymes. Values of ph can change between 5.5 and 7.5 in different tissues of healthy individuals (Livermore & Corkill, 1992), and the range may be even wider in patients suffering infectious diseases (Hamill & Maki, 1986; Gudmundson et al., 1991). It has been shown that changes in both extracellular and intracellular ph affect the expression of several genes (Olson, 1993). In general, bacteria are able to maintain the internal ph constant even when external ph changes by up to 2 units. However, it is known that internal ph cannot be maintained when bacteria are growing under stress conditions (Booth, 1985) and changes in external ph have been found to trigger transient changes of internal ph, which may produce changes in both the expression of certain genes such as the Escherichia coli SOS response (Dri & Moreau, 1994), and the activity of certain enzymes. In the present work, we have determined the kinetic constants of the aminoglycoside-inactivating enzyme 6'-JV-aminoglycoside acetyltransferase (AAC(6')IV) from Staphylococcus epidermidis using antibiotics of clinical interest. We have also evaluated the effect of 6'-aminosugar functional groups and of ph on the kinetic constants. Chemicals Materials and methods The antibiotics were obtained from the following suppliers: gentamicin and netilmicin from Shering Corp., Bloomfield USA, tobramycin from Eli Lilly & Co., Indianapolis USA, and amikacin from Bristol-Squibb Laboratories, Syracuse, USA. The radioactive compounds were obtained from Amersham UK. Lysozyme and lysostaphin were obtained from Sigma Chemical Co., St. Louis, USA. Antibiotic susceptibility tests Antibiotic susceptibility was evaluated by the Mueller-Hinton broth dilution technique, according to the protocols of the National Committee for Clinical Laboratory Standards (NCCLS, 1990). When needed, the medium was buffered at the desired ph with 0.1 M phosphate buffer. Aminoglycoside-modifying enzyme assays Bacterial extracts were prepared and the enzymes were assayed using the phosphocellulose paper-binding technique described previously (Haas & Dowding, 1975). The reaction was allowed to proceed for 30 min at 37 C. In the case of kinetic studies, assay mixtures contained the appropriate substrates, 0.1 M Tris-maleate buffer ph 5.5, 6.5 or 7.5, 10 mm MgCl 2, 2.5 mm dithiothreitol and 1 mm 1- M C-ACCOA (1500 cpm/nmol) in a total volume of 250 nl. Each reaction was started by the addition of 50 /il of the crude bacterial extracts. All kinetic studies were performed at 37 C, and determination of the kinetic constants was made as described (Culebras et al., 1994).

3 ph regulation of AAC(60 activity 883 Kinetic studies of acetyllransferase activity Results The clinical isolate 5. epidermidis RYC13036 (Culebras et al., 1994) harbouring the bifunctional enzyme AAC(6')IV-APH(2") (Le Goffic, Moreau & Masson, 1977) was used in our work. Since acetyltransferase activity is responsible for most of the aminoglycoside resistance in staphylococci, we analyzed the kinetic constants of this enzyme. As Table I shows, the acetyltransferase enzyme had a very high K m value for netilmicin and a very low value for tobramycin both at ph 5.5 and 6.5. At the same ph values, amikacin and gentamicin exhibited intermediate K m values. All these were lower at ph 7.5. At all ph values tested, the enzyme was most active against tobramycin and least active against netilmicin. The value of the V^. constant was also clearly dependent on ph, showing highest values at ph 6.5 using tobramycin, amikacin or gentamicin as substrates. At ph 7.5 these values were slightly lower and they were lower still at ph 5.5. Results with netilmicin were different, with K.^, values rising with increasing ph. As Table I shows, the Knu at ph 7.5 was three times higher than at ph 6.5, whereas at ph 5.5 the activity of the enzyme was nearly undetectable. Substrate inhibition ph influence As substrate inhibition might be relevant for the susceptibility to aminoglycosides of bacteria producing antibiotic-inactivating enzymes, we evaluated the K, of AAC(6')IV to tobramycin, gentamicin, amikacin and netilmicin. The analysis was performed at the same three ph values (5.5, 6.5 and 7.5) previously used for determining the K m and V mmi values. As Figure 1 shows, the type of 6'-aminosugar of the molecule (Figure 2) appeared to have a dramatic effect on the substrate inhibition. The members of the kanamycin family (with a glucosamine-like 6'-aminosugar) showed an inhibition that increased with increasing ph. The opposite was the case for the members of the gentamicin family (groups of aminoglycosides with garosamine) which presented the highest K t values at ph 7.5 (Table II). Also for all ph values tested, the K, values for gentamicin and netilmicin were large, which indicates that substrate inhibition is not significant for members of this family of aminoglycosides. Discussion It has been shown that the hydrolytic constant (V<mJKm) has a close relationship with MIC values for aminoglycoside-inactivating enzymes were compared (Radika & Northrop, 1984). With our strain, this relationship existed when MICs for tobramycin, amikacin and netilmicin, but not gentamicin. The strain used in this study has APH(2") activity, and since this is more active against gentamicin (Bongaerts & Vliegenthart, 1988), the phenotypic behaviour of S. epidermidis RYC13036 towards this antibiotic results from activities of both AAC(6'), and APH(2"), the second being especially active against gentamicin. Substrate inhibition was shown to be relevant for the kanamycins but not for the gentamicins. It has been suggested (Umezawa, Yagisawa & Sama, 1975) that the enzyme AACX60 has two substrate recognition regions, one being the catalytic region, the

4 Table 1. Apparent kinetic constants of AAC(6')IV and MICs of S. epidermidis RYC13036 at different phs Aminoglycoside Tobramycin Gentamicin Netilmicin ph m K m (JIM) ph ph (pmol/mg/min) ph5.5 ph6.5 ph ph b 'mmxf **-m ph ph MIC (mg/l) ph5. 5 ph 6.5 ph7.5 The value was too high to be measured accurately *Since the value of /f» was not obtainable for this antibiotic at ph 5.5. V^,/K m was not determined, but is assumed to be very low because the value for AC was very high w E. re 1 % s.

5 ph regulation of AAC(60 activity 885 ph5.5 ph6.5 ph i itain 1C Gei 20 n * t 1 i 1 i 1/v (mg.ml/pmol) Fignre 1. Kinetics of excess substrate inhibition: The K, values of AAC(6') from S. epidermidis at different phs were calculated using amikacin, tobramycin, netilmicin and gentamicin substrates.

6 886 E. Culebru et at. AMINOHEXOSE(') OH 2, 6 DIAMINE Gentamicin C Tbbramycin Netilmicin NH 2 3AMIN0HEXOSET) 0 (R): NHCCHCHJCHNHJ OH (R): NHCjHg Netilmicin 6AMINE Gentamicin B CHJNHJ GLUCOSAMINE Tbbramycin OH 2AMINE Gentamicin A GAROSAMINE Gentamicin Figure 2. Aminoglycoside structures, relevant features of amikacin, gentamicin, tobramycin and netilmicin are shown. other being involved in substrate inhibition. According to our results, both the \-N substituents and the aminohexose (3") are important for the inhibition. Hence, the glucosamine sugar increases substrate inhibition, since the K, values were much lower for tobramycin and amikacin than for the garosamine-containing aminoglycosides gentamicin and netilmicin. On the other hand, the fact that antibiotics with l-n substitutions (amikacin and netilmicin) had higher K t than their non-substituted counterparts (tobramycin and gentamicin), suggests that the \-N side chain reduces inhibition. The values of ph vary between different tissues, and also depend on the site of infection and underlying patient condition. Metabolic acidosis is a well-known complication of septic shock (Hamill & Maki, 1986). Although acidic ph has been Table II. Effect of ph on K { of different aminoglycosides K(HM) Aminoglycoside ph 5.5 ph 6.5 ph 7.5 Tobramycin Gentamicin Netilmicin

7 ph regulation of AAC(60 activity 887 shown to inhibit the cellular uptake of aminoglycosides (Damper & Epstein, 1981; Eisenberg et al., 1984), there is no available information on the effect of this on the activity of aminoglycoside-inactivating enzymes. In the case of AAC(6'), we have shown that the different functional groups in the antibiotic moiety influence the kinetic constants of the aminoglycoside-modifying-enzymes and hence help to determine the resistance to one specific aminoglycoside. Since ph affects the ionization state not only of these groups, but also of the groups of the amino-acids at the active site of the enzyme, this parameter may influence the antibiotic resistance mediated by AAQ60. We have shown that, in all cases, the values of V^/Km increased with ph, whereas this was not true for the values of K- At acidic ph, substrate inhibition did not occur. When ph increased, the values of K decreased for kanamycins, whereas they increased for gentamicins (Table II). Therefore, at neutral ph, substrate inhibition could be relevant for the kanamycins, whereas it is not important for the gentamicins. In fact, this inhibition counteracted the high value shown by V^/KM at high ph in the case of amikacin but not of tobramycin. Thus, at ph 7.5, amikacin was more effective than tobramycin and gentamicin against staphylococci harbouring AAC(6'). Despite the ten-fold lower value of Vm^/K m for netilmicin than for amikacin, substrate inhibition produced by amikacin resulted in there being less difference between MICs than might be anticipated. A similar effect was also detectable at ph 6.5, but differences in favour of amikacin were less marked because of the lower inhibition observed at this ph. At ph 5.5, the effect of substrate inhibition was overcome by the decrease in aminoglycoside permeability at low ph. The effect of ph on substrate inhibition may be important in clinical practice, and should also be considered in the design and development of new aminoglycosides. Our data indicate not only that aminoglycosides with glucosamine moeities interact with enzymes in a different way from those with garosamine, but also that kinetic constants for both groups of antibiotics vary in opposite directions in response to ph changes. The effect of ph on the kinetic constants of the /Mactamase TEM-1, as well as on the activity of different /J-lactam antibiotics against TEM-1-producing bacteria have been described previously (Livermore & Corkill, 1992). Detailed studies on the effect of ph on the activity of aminoglycoside-modifying enzymes have been published (Gates & Northrop, 1988), but we believe that this is the first report of the relationship between this effect and the activity of aminoglycosides against AAC(6') producing bacteria. These data point to a role of ph in modulating antibiotic resistance mediated by inactivating enzymes. The effect is seen not only on enzymatic activity {V^K^ and K,) but on the permeability of the organism for the antibiotic as well. Since antibiotics and enzymes (even those belonging to the same family) respond differently to ph changes, much more work is needed to clarify the role of this physiological effector on the mechanisms of antibiotic resistance. The understanding of this modulation might contribute to the development of new therapeutic protocols and to the design of new antibiotics. References Bongaerts, G. P. & Molendijik, L. (1984). Relation between aminoglycoside 2'-O-nucleotidyltransferasc activity and aminoglycoside resistance. Antimicrobial Agents and Chemotherapy 25,

8 888 E. Culebras el al. Bongaerts, G. P. & Vliegenthart, J. S. (1988). Effect of aminoglycoside concentration on reaction rates of aminoglycoside-modifying enzymes. Antimicrobial Agents and Chemotherapy 32, Booth, I. R. (1985). Regulation of cytoplasmic ph in bacteria. Microbiological Reviews 49, Bryan, L. E. (1984). Mechanisms of action of aminoglycoside antibiotics. In Contemporary Issues in Infectious Diseases, Vol. 1. New Dimensions in Antimicrobial Therapy (Root, R. K. & Sande, M. A., Eds), pp Churchill Livingstone, Edinburgh. Culebras, E., Perez-Diaz, J. C, Blazquez, J., Alonso, R. & Baquero, F. (1994). In-vitro synergy between aminogjycosides deployed against Staphylococcus spp. harbouring an 6'-aminoglycoside acetyltransferase, 2"-aminoglycoside phosphotransferase enzyme. Journal of Antimicrobial Chemotherapy 33, Damper, P. D. & Epstein, W. (1981). Role of the membrane potential in bacterial resistance to aminogjycoside antibiotics. Antimicrobial Agents and Chemotherapy 20, Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 264, de Lencastre, H., de Jonge, B. L., Matthews, P. R. & Tomasz, A. (1994). Molecular aspects of methicillin resistance in Staphvlococcus aureus. Journal of Antimicrobial Chemotherapy 33, Dri, A. & Moreau, V. (1994). Control of the LexA regulon by ph: evidence for a reversible inactivation of the LexA repressor during the growth cycle of Escherichia coli. Molecular Microbiology 12, Eisenberg, E. S., Mandel, L. J., Kaback, H. R. & Miller, M. H. (1984). Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. Journal of Bacteriology 157, Gates, C. A. & Northrop, D. B. (1988). Determination of the rate-limiting segment of aminoglycoside nucleotidyltransferase 2"-I by ph- and viscosity-dependent kinetics. Biochemistry 27, Graham, D. R. (1981). Gentamicin-resistant staphylococci. Lancet ii, 698. Gudmundsson, A., Erlendsdottir, H., Gottfredsson, M. & Gudmundsson, S. (1991). Impact of ph and cationic supplementation on in vitro postantibiotic effect. Antimicrobial Agents and Chemotherapy 35, Guimaraes, M. H., Sage, R. & Noone, P. (1985). The comparative activity of eleven aminocyclitol antibiotics against 773 aerobic Gram-negative rods and staphylococci isolated from infected hospitalized patients. Journal of Antimicrobial Chemotherapy 16, Haas, M. J. & Dowding, J. E. (1975). Aminoglycoside-modifying enzymes. Methods in Enzymology 43, Hamill, R. J. & Maki, D. K. (1986). Endotoxin shock in man caused by gram-negative bacilli. In Handbook of Endotoxin, Vol. 4. Clinical Aspects of Endotoxin Shock (Proctor, R. A., Ed.), pp Elsevier Science Publishers B. V. Amsterdam. Le Goffic, F., Moreau, N. & Masson, M. (1977). Are some aminoglycoside antibiotics inactivating enzymes polyfunctional? Annales de Microbwlogie 128B, Livermore, D. M. & Corkill, J. E. (1992). Effects of CO, and ph on inhibition of TEM-1 and other /Mactamases by penicillanic acid sulfones. Antimicrobial Agents and Chemotherapy 36, Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C, John, J. F., Korvick, J. A. et al. (1993). Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of Medicine 94, National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Second Edition: Approved Standard M7-A2. NCCLS. Villanova, PA. Olson, E. R. (1993). Influence of ph on bacterial gene expression. Molecular Microbiology 8, Radika, K. & Northrop, D. B. (1984). Correlation of antibiotic resistance with V^K, ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase. Antimicrobial Agents and Chemotherapy 25,

9 ph regulation of AAC(60 activity 889 Swartz, M. N. (1994). Hospital-acquired infections: diseases with increasingly limited therapies. Proceedings of the National Academy of Sciences USA 91, Thrupp, L. D. (1980). Susceptibility testing of antibiotics in liquid media. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp Williams & Wilkins Co., Baltimore. Umezawa, Y., Yagisawa, M., Sawa, T., Takeuchi, T. & Umezawa, H. (1975). Aminoglycoside 3'-phosphotransferase III, a new phosphotransferase resistance mechanism. Journal of Antibiotics 28, Wiedemann, B. & Krcsken, M. (1984). The incidence and development of resistance in Staphylococcus aureus from three European countries. Journal of Antimicrobial Chemotherapy 14, Suppl. D, Williams, J. W. & Northrop, D. B. (1978). Substrate specificity and structure-activity relationships of gentamicin acetyltransferase I. Journal of Biological Chemistry 253, {Received 25 July 1995; returned 22 August 1995; revised 15 September 1995; accepted 28 December 1995)

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa

More information

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",

More information

Plasmid-Mediated Aminoglycoside Phosphotransferase of

Plasmid-Mediated Aminoglycoside Phosphotransferase of ANTIMICROBIAL AGENTS AND CHzMoTHzRAPY, Apr. 1977, p. 619-624 Copyright C 1977 American Society for Microbiology Vol. 11, No. 4 Printed in U.S.A. Plasmid-Mediated Aminoglycoside Phosphotransferase of Broad

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

Derivative, 4'-Deoxy, 6'-N-Methylamikacin

Derivative, 4'-Deoxy, 6'-N-Methylamikacin ANTIMICROBLAL AGENTS AND CHEMOTHERAPY, Apr. 1981, p. 549-555 0066-4804/81/040549-07$02.00/0 Vol. 19, No. 4 Resistance to Antibiotic Synergism in Streptococcus faecalis: Further Studies with Amikacin and

More information

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation

More information

Antimicrobial Resistance

Antimicrobial Resistance Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

Antimicrobial Resistance Acquisition of Foreign DNA

Antimicrobial Resistance Acquisition of Foreign DNA Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Nocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda

Nocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda Cephamycins Cephamycins Antibiotics III. Cephamycin A-C, 1971, Str. lipmanii 7 -Methoxy group: Somewhat diminished antibacterial activity Resistant to a wide range of ß-lactamase enzymes 3-CH 2 -carbamoyl

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI

TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI J. MED. MICROBIOL. VOL.-20 (1985) 187-196 0 1985 The Pathological Society of Great Britain and Ireland TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI H. Y. CHEN* AND J. D.

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Antimicrobial Resistance

Antimicrobial Resistance Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Boosting Bacterial Metabolism to Combat Antibiotic Resistance

Boosting Bacterial Metabolism to Combat Antibiotic Resistance Boosting Bacterial Metabolism to Combat Antibiotic Resistance The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published

More information

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,

More information

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus 2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

More information

Microbiology ( Bacteriology) sheet # 7

Microbiology ( Bacteriology) sheet # 7 Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

Interpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain

Interpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain Interpretative reading of the antibiogram Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain ANTIBIOGRAM RESISTANCE SUSCEPTIBILITY ANTIMICROBIAL AGENT

More information

Factors affecting plate assay of gentamicin

Factors affecting plate assay of gentamicin Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical

More information

Burn Infection & Laboratory Diagnosis

Burn Infection & Laboratory Diagnosis Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Other Beta - lactam Antibiotics

Other Beta - lactam Antibiotics Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics

More information

by adding different antibiotics to sera containing

by adding different antibiotics to sera containing J. clin. Path., 1977, 30, 521-525 Serum gentamicin assays of 100 clinical serum samples by a rapid 40 C Kiebsiella method compared with overnight plate diffusion and acetyltransferase assays D. C. SHANSONI

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

Christiane Gaudreau* and Huguette Gilbert

Christiane Gaudreau* and Huguette Gilbert Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter

More information

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

Origins of Resistance and Resistance Transfer: Food-Producing Animals. Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter

More information

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method Journal of Antimicrobial Chemotherapy (1988) 22, 23-33 Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method Barforo Isaksson'*, Lennart Nibson*, Rolf Mailer' and

More information

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What

More information

Introduction to antimicrobial agents

Introduction to antimicrobial agents Introduction to antimicrobial agents Kwan Soo Ko Action mechanisms of antimicrobials Bacteriostatic agents, such as tetracycline - Inhibit the growth and multiplication of bacteria - Upon exposure to a

More information

Jan A. Jacobs* and Ellen E. Stobberingh

Jan A. Jacobs* and Ellen E. Stobberingh Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)

More information

Antimicrobial agents

Antimicrobial agents Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original

More information

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and

More information

Protein Synthesis Inhibitors

Protein Synthesis Inhibitors Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors

More information

Aminoglycoside-resistant enterococci

Aminoglycoside-resistant enterococci Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program

More information

Why we perform susceptibility testing

Why we perform susceptibility testing 22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform

More information

Antibiotic Susceptibility of Pseudomonas aeruginosa

Antibiotic Susceptibility of Pseudomonas aeruginosa ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine

More information

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department

More information

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia

More information

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

UDC: : :579.22/ :615.28

UDC: : :579.22/ :615.28 www.imiamn.org.ua /journal.htm 8 UDC: 6.33:61.017.1:579./.841.9:6.8 SUBSTANTIATION OF OVERCOMING OF ANTIBIOTIC RESISTANCE IN ACINETOBACTER BAUMANNII CLINICAL STRAINS BY USAGE OF DECAMETHOXINUM Nazarchuk

More information

Mechanisms and Pathways of AMR in the environment

Mechanisms and Pathways of AMR in the environment FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14

More information

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and

More information

Pharmacological Evaluation of Amikacin in Neonates

Pharmacological Evaluation of Amikacin in Neonates ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

More information

VOL. XXX NO. 8 THE JOURNAL OF ANTIBIOTICS 655 RESISTANCE OF BACTERIA TO THE NEWER AMINOGLYCOSIDE ANTIBIOTICS: AN EPIDEMIOLOGICAL AND ENZYMATIC STUDY

VOL. XXX NO. 8 THE JOURNAL OF ANTIBIOTICS 655 RESISTANCE OF BACTERIA TO THE NEWER AMINOGLYCOSIDE ANTIBIOTICS: AN EPIDEMIOLOGICAL AND ENZYMATIC STUDY VOL. XXX NO. 8 THE JOURNAL OF ANTIBIOTICS RESISTANCE OF BACTERIA TO THE NEWER AMINOGLYCOSIDE ANTIBIOTICS: AN EPIDEMIOLOGICAL A ENZYMATIC STUDY MARLYSE DEVAUD, FRITZ H. KAYSER and URSUL.A HUBER Institute

More information

Advance Access published September 16, 2004

Advance Access published September 16, 2004 Advance Access published September 16, 2004 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh435 JAC Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and

More information

Received 17 December 2003; accepted 22 December 2003

Received 17 December 2003; accepted 22 December 2003 Journal of Antimicrobial Chemotherapy (2004) 53, 609 615 DOI: 10.1093/jac/dkh130 Advance Access publication 3 March 2004 In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines,

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus B-O-021 Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus Nongluk Autarkool *a, Yothin Teethaisong a, Sajeera Kupittayanant b, Griangsak Eumkeb a

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria

More information

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018 β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

Antibacterial Agents & Conditions. Stijn van der Veen

Antibacterial Agents & Conditions. Stijn van der Veen Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only

More information

ANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE

ANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE ANTIMICROBIAL TESTING with ALKA VITA (ALKAHYDROXY ) on ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE FINAL RESULTS OF ANTIBACTERIAL TESTS IN VITRO WITH THE PRODUCT

More information

D-Lactic Acid Production as a Monitor of the Effectiveness

D-Lactic Acid Production as a Monitor of the Effectiveness ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1991, p. 237-241 Vol. 35, No. 2 0066-4804/91/020237-05$02.00/0 Copyright 1991, American Society for Microbiology D-Lactic Acid Production as a Monitor of the

More information

Studies on Antibiotic Synergism Against Enterococci

Studies on Antibiotic Synergism Against Enterococci Studies on Antibiotic Synergism Against Enterococci II. EFFECT OF VARIOUS ANTIBIOTICS ON THE UPTAKE OF 4C-LABELED STREPTOMYCIN BY ENTEROCOCCI ROBERT C. MOELLERING, JR. and ARNOLD N. WEINBERG From the Infectious

More information

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone

More information

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ Antibiotic resistance is rapidly emerging as a public health issue throughout the world. Mankind has enjoyed about half a century of virtual complete control

More information

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,

More information

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information